CLN5 | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

77 results for “CLN5”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Active, not recruiting

Gene Therapy Study for Children With CLN5 Batten Disease

6 participants · First posted Feb 8, 2022

A Natural History Study of Neuronal Ceroid Lipofuscinosis Type 5 (CLN5)

37 participants · First posted Jan 30, 2019

Natural History and Longitudinal Clinical Assessments in NCL / Batten Disease, the International DEM-CHILD Database

500 participants · First posted Nov 3, 2020

Clinical and Neuropsychological Investigations in Batten Disease

500 participants · First posted Jun 10, 2013

Not yet recruiting

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in Pediatric Patients (Master Protocol)

24 participants · First posted Jul 31, 2026

Active, not recruiting

Study for the Treatment for CLN7 Disease

4 participants · First posted Feb 3, 2021

Natural History Study of Batten Disease

10 participants · First posted Nov 25, 2020

Approved For Marketing

A Multicenter, Multi-national Open-label Program to Provide BMN 190 to Patients Diagnosed With CLN2 Disease

First posted Nov 15, 2016

Phase 1/2 Study of CLN-081 in Patients with Lung Cancer

63 participants · First posted Sep 23, 2024

Active, not recruiting

Gene Therapy for Children With CLN3 Batten Disease

7 participants · First posted Dec 10, 2018

Page 1 of 5